St. Louis University School of Medicine recently announced medical research grants from the National Institutes of Health. This St. Louis based institution offers leading research infrastructure and investigators in the Midwest.
The grants include the following:
· Nicola Pozzi, assistant professor of biochemistry and molecular biology received $1.96 million from the National Heart, Lung and Blood Institute to investigate the role of beta-2 To investigate the role of beta-2 glycoprotein I in antiphospholipid syndrome (APS), a disorder of the immune system.
· John Tavis, professor of molecular microbiology and immunology received $1.88 million from the National Institutes of Health to study the effects of HBV RNaseH inhibitors on the hepatitis B virus.
· Daniela Salvemini, professor of pharmacology and physiology and director of the Henry and Amelia Nasrallah Center for Neuroscience at St. Louis University, and Susan Farr, professor of geriatric medicine and research health science at the St. Louis VA received $1.3 million from the NIH to investigate novel approaches for traumatic brain injury induced cognitive deficits.
About St. Louis University School of Medicine
Founded in 1836, the St. Louis University School of Medicine (SLUSOM) is a private, American medical school within Saint Louis University located in the city of St. Louis. Comprising about 700 medical students and 550 faculty members and another 550 residents in 48 graduate medical education programs including residencies and subspecialties. They are considered a leading research center in five key areas including cancer, infectious disease, liver disease, aging and brain disorders, and heart/lung disease. The center provides health services on a local, national and international level while conducting medical research and training physicians and biomedical scientists of the future. Cardinal Glennon Children’s Hospital and St. Louis University Hospital are the two main affiliated teaching hospitals of the school.